Availability of a protective gear as he was honoring her on National Nurse day. Good to have you with us. Only a handful of u. S. States are resisting the trend to reopen businesses and public spaces even as the country racks up new cases and more deaths each day. Johns Hopkins University says the u. S. Has 1. 2 million cases and more than 73,000 deaths and disease experts warn that not one of the 43 states planning to relax restrictions has met the white houses guidelines for reopening. Los angeles will allow many Retail Stores to reopen beginning friday albeit with curbside service. Car dealerships will also return. This dire warning from the former head of the u. S. Centers for Disease Control and prevention. Its really bad. In new york city its on the order of the 1918, 1919 pandemic. More than 20,000 people when you look at all of the excess deaths in the last two months killed in less than two months. That is as bad as the worst phase of the pandemic 100 years ago. Even now with
Tech Mahindra expects to begin trials for planned COVID drug in 3-4 months
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Tech Mahindra expects to begin trials for planned Covid drug in 3-4 months
orissapost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from orissapost.com Daily Mail and Mail on Sunday newspapers.
Tech Mahindra, Reagene to file patent for molecule that potentially attacks coronavirus
SECTIONS
Last Updated: May 02, 2021, 06:48 PM IST
Share
Synopsis
Tech Mahindra Global Head (Makers Lab) Nikhil Malhotra told that the company along with its partner is applying for patenting on which further testing will be done. Markers Lab is the research and development arm of Tech Mahindra.
Getty Images
IT company
Tech Mahindra is in the process of filing a patent, along with Reagene Biosciences, for a drug molecule that can potentially attack coronavirus, according to a senior company official. Tech Mahindra Global Head (Makers Lab) Nikhil Malhotra told that the company along with its partner is applying for patenting on which further testing will be done.
IT company Tech Mahindra is in the process of filing a patent, along with Reagene Biosciences, for a drug molecule that can potentially attack coronavirus, according to a senior company official.
Tech Mahindra Global Head (Makers Lab) Nikhil Malhotra told PTI that the company along with its partner is applying for patenting on which further testing will be done. Markers Lab is the research and development arm of Tech Mahindra. We have found a molecule that can potentially attack coronavirus. We have applied for a joint patent and cannot reveal the name of the molecule unless the patent process is completed, Malhotra said.